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Abstract 
Background Objective: Postoperative shivering is one of the common problems following 
general anesthesia and may lead to multiple complications. This study was designed to 
evaluate the effect of prophylactic administration of intravenous (IV) ketorolac in 
comparison with Pethidine on shivering, during the first minutes following surgery in the 
recovery period. 
 
Methods: In a randomized, double blind clinical trial, Sixty patients with American 
Society of Anesthesiologists physical status I and II, in the age range of 20 to 60 years 
who were scheduled for abdominal surgery (cholecystectomy and laparotomy) under 
general anesthesia, were randomly assigned to two groups which received (a non-
selective COX inhibitor) 30 mg of ketorolac or 0.5 mg/kg of pethidine (meperidine) 
intravenously, 20–30 minutes before completion of surgery. The incidence and grades of 
postoperative shivering and pain intensity score were recorded during the recovery 
period. 
 
Results: There were no differences in demographic data, surgery duration and 
postoperative pain score in both groups. Postoperative shivering was observed in 4 
patients in group pethidine (13.33%), compared with seven in group ketorolac (23.33%) 
(P = 0.36). 
Postoperative nausea and vomiting, in recovery occurred more frequently in the Pethidine 
group as compared to the ketorolac group (P=0.016). 
 
Conclusion: Ketorolac in a dose of 30mg IV, 20–30 minutes before completion of surgery 
is as effective as pethidine 0.5 mg/kg IV as an anti-shivering and is associated with 
significantly less postoperative nausea and vomiting. 
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